RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Anebulo Pharmaceuticals Stock

Anebulo Pharmaceuticals Equity 2025

Anebulo Pharmaceuticals Equity

3.81 M USD

Ticker

ANEB

ISIN

US0345691036

WKN

A3CM1D

In 2025, Anebulo Pharmaceuticals's equity was 3.81 M USD, a -64.03% increase from the 10.6 M USD equity in the previous year.

Anebulo Pharmaceuticals Aktienanalyse

What does Anebulo Pharmaceuticals do?

Anebulo Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Anebulo Pharmaceuticals's Equity

Anebulo Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Anebulo Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Anebulo Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Anebulo Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Anebulo Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Anebulo Pharmaceuticals stock

What is the equity of Anebulo Pharmaceuticals this year?

Anebulo Pharmaceuticals has equity of 3.81 M USD this year.

What was the equity of Anebulo Pharmaceuticals compared to the previous year?

The equity of Anebulo Pharmaceuticals has increased/decreased by -64.03% decreased compared to the previous year.

What impact does a high equity have on investors of Anebulo Pharmaceuticals?

A high equity is advantageous for investors of Anebulo Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Anebulo Pharmaceuticals?

A low equity can be a risk for investors of Anebulo Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Anebulo Pharmaceuticals affect the company?

An increase in equity of Anebulo Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Anebulo Pharmaceuticals affect the company?

A reduction in equity of Anebulo Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Anebulo Pharmaceuticals?

Some factors that can affect the equity of Anebulo Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Anebulo Pharmaceuticals so important for investors?

The equity of Anebulo Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Anebulo Pharmaceuticals take to change the equity?

To change equity, Anebulo Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Anebulo Pharmaceuticals pay?

Over the past 12 months, Anebulo Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Anebulo Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Anebulo Pharmaceuticals?

The current dividend yield of Anebulo Pharmaceuticals is .

When does Anebulo Pharmaceuticals pay dividends?

Anebulo Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Anebulo Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Anebulo Pharmaceuticals located?

Anebulo Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Anebulo Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Anebulo Pharmaceuticals from 3/2/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/2/2025.

When did Anebulo Pharmaceuticals pay the last dividend?

The last dividend was paid out on 3/2/2025.

What was the dividend of Anebulo Pharmaceuticals in the year 2024?

In the year 2024, Anebulo Pharmaceuticals distributed 0 USD as dividends.

In which currency does Anebulo Pharmaceuticals pay out the dividend?

The dividends of Anebulo Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Anebulo Pharmaceuticals

Our stock analysis for Anebulo Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Anebulo Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.